We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-13.72%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.35B
AUM Growth
-$2.4B
Cap. Flow
-$757M
Cap. Flow %
-8.1%
Top 10 Hldgs %
23.15%
Holding
300
New
33
Increased
109
Reduced
94
Closed
43

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$66.5M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$62.4M
3
TMO icon
Thermo Fisher Scientific
TMO
+$53.8M
4
ANET icon
Arista Networks
ANET
+$47M
5
BSX icon
Boston Scientific
BSX
+$45.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$112M
2
AMGN icon
Amgen
AMGN
+$102M
3
AAPL icon
Apple
AAPL
+$102M
4
ATVI
Activision Blizzard
ATVI
+$72.8M
5
FLEX icon
Flex
FLEX
+$70.4M

Sector Composition

Rank Sector Weight
1 Technology 25.47%
2 Financials 23.51%
3 Healthcare 21.25%
4 Communication Services 7.66%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
126
Sarepta Therapeutics
SRPT
$1.63B
$21.9M 0.23%
200,482
+150,482
+301% +$18.8M
STML
127
DELISTED
Stemline Therapeutics, Inc.
STML
$21.9M 0.23%
2,302,666
+248,616
+12% +$3.22M
ALNY icon
128
Alnylam Pharmaceuticals
ALNY
$38.5B
$21.5M 0.23%
294,287
+50,000
+20% +$3.85M
RLI icon
129
RLI Corp
RLI
$5.97B
$20.9M 0.22%
607,000
-10,000
-2% -$363K
VRTX icon
130
Vertex Pharmaceuticals
VRTX
$124B
$20.7M 0.22%
125,000
-95,000
-43% -$16.5M
ALTR
131
DELISTED
Altair Engineering Inc
ALTR
$20.3M 0.22%
+735,844
New +$24.3M
TPL icon
132
Texas Pacific Land
TPL
$26.9B
$20.2M 0.22%
335,385
+77,553
+30% +$5.59M
AMG icon
133
Affiliated Managers Group
AMG
$9.78B
$20M 0.21%
205,490
+1,398
+0.7% +$158K
AMGN icon
134
Amgen
AMGN
$212B
$19.7M 0.21%
101,075
-525,000
-84% -$102M
LHCG
135
DELISTED
LHC Group LLC
LHCG
$19.5M 0.21%
208,234
-61,924
-23% -$5.92M
OLED icon
136
Universal Display
OLED
$3.85B
$19.1M 0.2%
204,530
+5,390
+3% +$544K
AFL icon
137
Aflac
AFL
$65.9B
$19M 0.2%
417,000
-8,000
-2% -$356K
HRTG icon
138
Heritage Insurance Holdings
HRTG
$905M
$18.8M 0.2%
1,278,500
-21,500
-2% -$320K
LITE icon
139
Lumentum
LITE
$50.7B
$18.8M 0.2%
447,464
+14,102
+3% +$694K
GLW icon
140
Corning
GLW
$108B
$18.6M 0.2%
617,284
-687,596
-53% -$21.9M
MDC
141
DELISTED
M.D.C. Holdings, Inc.
MDC
$18.6M 0.2%
773,336
-332,419
-30% -$8.04M
CVS icon
142
CVS Health
CVS
$140B
$18M 0.19%
+275,000
New +$20.5M
CELG
143
DELISTED
Celgene Corp
CELG
$17.6M 0.19%
275,000
-160,000
-37% -$11.8M
PPLI
144
People Inc
PPLI
$3.13B
$16.6M 0.18%
508,315
+44,478
+10% +$1.49M
AGIO icon
145
Agios Pharmaceuticals
AGIO
$2.14B
$15.4M 0.17%
335,000
-267,342
-44% -$16.5M
PVG
146
DELISTED
PRETIUM RESOURCES INC.
PVG
$15.4M 0.17%
+1,826,630
New +$14.3M
BIIB icon
147
Biogen
BIIB
$30.4B
$15M 0.16%
50,000
-25,000
-33% -$7.98M
GILD icon
148
Gilead Sciences
GILD
$167B
$14.1M 0.15%
225,000
+24,896
+12% +$1.74M
TD icon
149
Toronto Dominion Bank
TD
$199B
$13.9M 0.15%
229,749
-3,681
-2% -$202K
BNFT
150
DELISTED
Benefitfocus, Inc.
BNFT
$13.9M 0.15%
303,854
+18,365
+6% +$767K
4 5
6
7 8

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Polar Capital held 300 positions worth $9.35B, down 20% from $11.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital withdrew a net $757M in Q4 2018, closing 43 positions and reducing 94 holdings. Its most notable exit was Activision Blizzard, an estimated $72.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Polar Capital opened a new position in Boston Scientific worth $44.2M.

  • Polar Capital's largest Q4 2018 buy was Boston Scientific: 1,250,000 shares worth $44.2M.
  • Polar Capital added most to Danaher in Q4 2018, an estimated $66.5M increase.
  • Polar Capital's biggest Q4 2018 reduction was Merck, cutting an estimated $112M.
  • Polar Capital fully exited Activision Blizzard in Q4 2018, selling an estimated $72.8M.
  • Polar Capital's ten largest holdings make up 23% of its $9.35B portfolio in Q4 2018.
  • Polar Capital opened 33 new positions and closed 43 in Q4 2018.
  • Polar Capital's portfolio value fell 20% quarter-over-quarter to $9.35B.

Based on Polar Capital's 13F filing for Q4 2018, filed 14 Feb 2019.